Tamarit OR, Ibañez RR, Hueso GL, Gonzalvez PJL

Language: Spanish
References: 9
Page: 56-59
PDF size: 1672.66 Kb.

ABSTRACT

Sarcoidosis is a multisystemic disorder characterized histollogically by epithelioid granulomas without caseating necrosis. Cutaneous involvement occurs in 20-35% of patients with systemic sarcoidosis and may occur without systemic involvement. A patient with cutaneous sarcoidosis, without systemic involvement is reported. Cutaneous lesions do not responsive to various forms of topical and systemic treatment and finally were responsive to metotrexate. We review treatment options for cutaneous sarcoidosis.

REFERENCES

1. Rajani K. Cutaneous Sarcoidosis: A dermatologic masquerader. Am Fam Phis 2002; 65: 1581-84.

2. BallGT, Kho GT, Martinka M. The histológic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 2004; 31: 160-8.

3. Blessing K. Cutaneous granulomatous inflammation. Curr Diagn Pathol 2005; 11: 219-35.

4. Baughman RP, Lower EE. Newer therapies for cutaneous sarcoidosis. The role of thalidomide and other agents. Am J Clin Dermatol 2004; 5: 385-94.

5. Baughman RP, Castabel U, De Bois RM. Treatment of Sarcoidosis. Clin Chest Med 2008: 533-48.

6. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 2002; 147: 154-6.

7. Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs 2008; 68: 1361-83.

8. Roos S, RaulinC, Ochenfels HS, Karsai S. Successful treatment of cutaneous sarcoidosis lesions whith the Flashlamp Pumped Pulsed Dye Laser. Dermatol Surg 2009: 1139-40.

9. Wilsmann-Theis D, Bieber T, Novak N. Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis. Dermatology 2008; 217: 343-6.